Brief: Strides Pharma Science Unit To Divest 100% Stake In Eris Pharma GmbH, Germany
Jan 11 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* UNIT ENTERED INTO A SHARE PURCHASE AGREEMENT FOR
DIVESTMENT OF
100% SHAREHOLDING IN ERIS PHARMA GMBH, GERMANY
* DEAL FOR EURO 200,000
Source text for Eikon: ID:nBSE3vsMl7
Further company coverage: SRID.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees